openPR Logo
Press release

Bio-Synthesis Expands Proteomic Platform with Enhanced Peptide Tools

02-01-2012 06:09 AM CET | Science & Education

Press release from: Bio-Synthesis, Inc.

LEWISVILLE, TX- January 31, 2012 – Bio-Synthesis Inc. (BSI), is proud to announce new peptide tools that can help researchers analyze and design their peptides more accurately and efficiently. By utilizing BSI’s homepage (, users will have access to the Peptide Property Calculator, as well as the Peptide Library Design Tools.

The peptide property calculator is a comprehensive web-based tool which calculates the various physiochemical property of the protein sequence. This tool calculates properties like Chemical formulae, Molecular weight, Isoelectric point, Extinction Co-efficient, and more. The property calculator can also predict hydrophobic or hydrophyllic regions, secondary structures, transmembrane regions, flexible regions and the probability of input sequence on the surface of the cell.

The Peptide property Calculator can also handle any junk character entered by the user which would be impassively removed from the input sequence. End users are guided step-by-step to make use of the tool from the beginning to end and also to interpret the results coming out of the tool. Easy-to-use features allow for amino acid sequences to be entered in single letter code or even the three letter code. The resulting graph surfacing from the hydrophobicity and hydrophilicity plot can be exported or copied to various locations and scrutinized. The calculation of each feature in the tool is based on the algorithm taken from reference papers.

Bio-Synthesis has also implemented Peptide Library Design Tools to its rapid high-throughput parallel peptide synthesis platform. These seven powerful peptide library generation tools provide researchers with the ability to generate large numbers of screening peptides which involves epitope mapping, sequence optimization, and sequence stabilization. The designs can include libraries made from Overlapping, Alanine Scanning, Positional, Truncation, Random, Scramble, and T-Cell Truncated peptides.

The advanced tools are added to a long list of design programs provided by Bio-Synthesis. With the Peptide Property Calculation and the Peptide Library Design Tools now available, researchers can analyze their sequences and make immediate adjustments to their project.

About Bio-Synthesis

Bio-Synthesis is a manufacturer of custom peptide synthesis, antibodies, bioconjugates, DNA, RNA, PNA, organic synthesis, microarrays, gene synthesis, cloning, detection kits, cell line authentication, and a diverse number of bimolecular products for the biomedical/life science community worldwide.

With over 27 years of experience producing custom products for both research and pharmaceutical use, BSI has developed a reputation for both small and large scale synthesis using optimal processes that meet your specifications. BSI is a U.S. based company, therefore all products are exclusively manufactured at the state-of-the-art facilities in Lewisville, Texas.

Bio-Synthesis, Inc.
612 East Main Street
Lewisville, TX 75057

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bio-Synthesis Expands Proteomic Platform with Enhanced Peptide Tools here

News-ID: 209139 • Views: 1513

More Releases for Peptide

Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established
What's driving the Customized Peptide Synthesis Market Growth? | Key Players are …
The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology. Download free report sample at: There are two main types of products available in the customized peptide synthesis
Customized Peptide Synthesis Market 2019-2024 by Top Key Players are GenScript, …
Customized peptide synthesis market is forecasted to generate revenue of $390.0 million by 2024. The market is mainly driven by increasing investments and funding for protein-based research, technological innovations, growing burden of cancer and infectious diseases, and increasing research activities in the field of synthetic biology. Download free report sample at: The different types of products available in the customized peptide synthesis market are reagents and equipment. Reagents category is expected
Peptide Synthesis Market Increasing Demand & Latest Trend with Genscript, AnaSpe …
HTF MI recently introduced United States Peptide Synthesis Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Bachem, PolyPeptide, GL Biochem, Xinbang, Hybio, USVPeptides, Thermofischer, ScinoPharm, Genscript,
Global Peptide Therapeutics Market: Cancer Treatment to Surface as Key Applicati …
Market Research Reports Search Engine (MRRSE) has been acting as an impressive data source when it comes to evaluating various industrial verticals. The research report titled “Global Peptide Therapeutics Market” offers a clear insight about the Peptide Therapeutics assessed over the global platform. This analysis proves beneficial for readers & new investors who are aiming to enter the market for Peptide Therapeutics in the near future. Click to Request a Sample:
Peptide Based Cancer Therapeutics Marke For peptide based cancer therapeutics ov …
About Peptide Based Cancer Therapeutics Market Popularity of peptide based cancer therapeutics is on the rise, owing to the positive outlook on their efficiency in treating cancer. According to the latest report published by Fact.MR, the global market for peptide based cancer therapeutics is set to reflect an above average CAGR during 2017 to 2022, to reach a valuation in excess of US$ 11,100 Mn. Incessant development in drug